Nigel Scrutton

Dr. Nigel Scrutton

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2006 in Science
Verified
Journal Article
Closed access
PDF file
LMLaura Masgrau
Laura Masgrau
ARAnna Roujeinikova
Anna Roujeinikova
LJLinus O. Johannissen
Linus O. Johannissen
PHParvinder Hothi
Parvinder Hothi
JBJaswir Basran
Jaswir Basran
DLDavid Leys
David Leys
We present an atomic-level description of the reaction chemistry of an enzyme-catalyzed reaction dominated by proton tunneling. By solving structures of reaction intermediates at near-atomic resolution, we have identified the reaction pathway for tryptamine oxidation by aromatic amine dehydrogenase. Combining experiment and computer simulation, we show proton transfer occurs predominantly to oxygen O2 of Asp 128 β in a reaction dominated by tunneling over ∼0.6 angstroms. The role of long-range coupled motions in promoting tunneling is controversial. We show that, in this enzyme system, tunneling is promoted by a short-range motion modulating proton-acceptor distance and no long-range coupled motion is required.

20 March 2018 in ACS Catalysis
Verified
Journal Article
Closed access
HTHelen S. Toogood
Helen S. Toogood
NSNigel Scrutton
Nigel Scrutton

30 July 2010 in ChemCatChem
Verified
Journal Article
Closed access
PDF file
HTHelen S. Toogood
Helen S. Toogood
JGJohn M. Gardiner
John M. Gardiner
NSNigel Scrutton
Nigel Scrutton

8 June 2018 in Communications Biology
Verified
Journal Article
Open access
PDF file
PCPablo Carbonell
Pablo Carbonell
AJAdrian J. Jervis
Adrian J. Jervis
CRChristopher J. Robinson
Christopher J. Robinson
CYCunyu Yan
Cunyu Yan
MDMark Dunstan
Mark Dunstan
NSNigel Scrutton
Nigel Scrutton
The microbial production of fine chemicals provides a promising biosustainable manufacturing solution that has led to the successful production of a growing catalog of natural products and high-value chemicals. However, development at industrial levels has been hindered by the large resource investments required. Here we present an integrated Design–Build-Test–Learn (DBTL) pipeline for the discovery and optimization of biosynthetic pathways, which is designed to be compound agnostic and automated throughout. We initially applied the pipeline for the production of the flavonoid (2S)-pinocembrin inEscherichia coli, to demonstrate rapid iterative DBTL cycling with automation at every stage. In this case, application of two DBTL cycles successfully established a production pathway improved by 500-fold, with competitive titers up to 88 mg L−1. The further application of the pipeline to optimize an alkaloids pathway demonstrates how it could facilitate the rapid optimization of microbial strains for production of any chemical compound of interest.

26 January 2021 in Quantum Reports
Verified
Journal Article
Open access
PDF file
YKYoungchan Kim
Youngchan Kim
FBFederico Bertagna
Federico Bertagna
EDEdeline M. D’souza
Edeline M. D’souza
DHDerren Heyes
Derren Heyes
LJLinus O. Johannissen
Linus O. Johannissen
JMJohnjoe Mcfadden
Johnjoe Mcfadden
Understanding the rules of life is one of the most important scientific endeavours and has revolutionised both biology and biotechnology. Remarkable advances in observation techniques allow us to investigate a broad range of complex and dynamic biological processes in which living systems could exploit quantum behaviour to enhance and regulate biological functions. Recent evidence suggests that these non-trivial quantum mechanical effects may play a crucial role in maintaining the non-equilibrium state of biomolecular systems. Quantum biology is the study of such quantum aspects of living systems. In this review, we summarise the latest progress in quantum biology, including the areas of enzyme-catalysed reactions, photosynthesis, spin-dependent reactions, DNA, fluorescent proteins, and ion channels. Many of these results are expected to be fundamental building blocks towards understanding the rules of life.

13 January 2016 in Journal of the American Chemical Society
Verified
Journal Article
Open access
TKTanja Knaus
Tanja Knaus
CPCaroline E. Paul
Caroline E. Paul
CLColin W. Levy
Colin W. Levy
SVSimon de Vries
Simon de Vries
FMFrancesco G. Mutti
Francesco G. Mutti
NSNigel Scrutton
Nigel Scrutton
The search for affordable, green biocatalytic processes is a challenge for chemicals manufacture. Redox biotransformations are potentially attractive, but they rely on unstable and expensive nicotinamide coenzymes that have prevented their widespread exploitation. Stoichiometric use of natural coenzymes is not viable economically, and the instability of these molecules hinders catalytic processes that employ coenzyme recycling. Here, we investigate the efficiency of man-made synthetic biomimetics of the natural coenzymes NAD(P)H in redox biocatalysis. Extensive studies with a range of oxidoreductases belonging to the “ene” reductase family show that these biomimetics are excellent analogues of the natural coenzymes, revealed also in crystal structures of the ene reductase XenA with selected biomimetics. In selected cases, these biomimetics outperform the natural coenzymes. “Better-than-Nature” biomimetics should find widespread application in fine and specialty chemicals production by harnessing the power of high stereo-, regio-, and chemoselective redox biocatalysts and enabling reactions under mild conditions at low cost.